Yueming Wu Selected Research

Yueming Wu Research Topics

Disease

6	Neoplasms (Cancer) 04/2024 - 05/2017
5	Infections 11/2023 - 08/2015
3	Sepsis (Septicemia) 03/2024 - 01/2023
3	Hemolysis 07/2022 - 01/2020
2	Cross Infection (Nosocomial Infection) 09/2023 - 01/2020
2	Bacterial Infections (Bacterial Infection) 12/2021 - 01/2021
1	Heart Failure 03/2024
1	Systolic Heart Failure 03/2024
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 03/2024
1	Meningitis 11/2023
1	Testicular Neoplasms (Testicular Cancer) 06/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	Brain Concussion (Cerebral Concussion) 11/2022
1	Hyperplasia 10/2022
1	Ventilator-Associated Pneumonia 08/2022
1	Critical Illness (Critically Ill) 08/2022
1	Bacteremia 08/2022
1	Septic Shock (Toxic Shock Syndrome) 08/2022
1	Communicable Diseases (Infectious Diseases) 07/2022
1	Invasive Fungal Infections 01/2022
1	Circulating Neoplastic Cells 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Dehydration (Water Stress) 08/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Body Weight (Weight, Body) 12/2018
1	Stomach Neoplasms (Stomach Cancer) 05/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Disease Progression 01/2017
1	Biliary Fistula 12/2016
1	Disease Resistance 01/2016
1	Inflammation (Inflammations) 01/2016
1	Thymoma (Thymic Carcinoma) 08/2015

Drug/Important Bio-Agent (IBA)

9	Peptides (Polypeptides)IBA 04/2024 - 01/2020
7	PolymersIBA 04/2024 - 01/2020
5	Proteins (Proteins, Gene)FDA Link 06/2023 - 12/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2024 - 05/2017
2	LipopolysaccharidesIBA 03/2024 - 01/2023
2	Antifungal AgentsIBA 11/2023 - 01/2022
2	Therapeutic UsesIBA 09/2023 - 01/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2022 - 01/2020
2	Antimicrobial Cationic PeptidesIBA 01/2022 - 01/2016
1	Biocompatible Materials (Biomaterials)IBA 09/2023
1	Piwi-Interacting RNAIBA 06/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	Pyruvic Acid (Pyruvate)IBA 01/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	ImmunosorbentsIBA 01/2023
1	EnzymesIBA 01/2023
1	NeurocalcinIBA 11/2022
1	CalciumIBA 11/2022
1	Biomarkers (Surrogate Marker)IBA 11/2022
1	ORALIT (ORS)IBA 08/2022
1	Polymyxin B (Aerosporin)FDA LinkGeneric 08/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	Cell-Penetrating PeptidesIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	GoldIBA 01/2021
1	lithium hexamethyldisilazideIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Angiopoietin-2IBA 01/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019
1	LigandsIBA 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 05/2017
1	7,3'-dihydroxy-4'-methoxyisoflavoneIBA 05/2017
1	Cisplatin (Platino)FDA LinkGeneric 05/2017
1	Transcription Factors (Transcription Factor)IBA 05/2017
1	130-nm albumin-bound paclitaxelIBA 01/2017
1	Serum AlbuminIBA 12/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2016
1	Butyrates (Butyrate)IBA 01/2016
1	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 08/2015

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 04/2024 - 01/2017
3	Therapeutics 03/2024 - 08/2022
2	Punctures 11/2023 - 01/2023
2	Immunotherapy 11/2023 - 01/2023
2	Ligation 11/2023 - 01/2023
1	Cardiac Resynchronization Therapy 03/2024
1	Heart Transplantation (Grafting, Heart) 03/2024
1	Thymectomy 08/2015